Foamy virus: an available vector for gene transfer in neural cells and other nondividing cells

References

• Achong BG, Mansell PW, Epstein MA, Clifford P (1971). An unusual virus in cultures from a human nasopharyngeal carcinoma. J Natl Cancer Inst 46:299–307.
   PubMed Web of Science ®Google Scholar
• Bauer TR Jr, Allen JM, Hai M, Tuschong LM, Khan IF, Olson EM, Adler RL, Burkholder TH, Gu YC, Russe DW, Hickstein DD (2008). Successful treatment of canine leukocyte adhesion deficiency by foamy virus vectors. Nat Med 14:93–97.
   PubMed Web of Science ®Google Scholar
• Blau H, Khavari P (1997). Gene therapy, progress, problems, prospects. Nat Med 3:612–613.
   PubMedGoogle Scholar
• Campbell M, Eng C, Luciw PA (1996). The simian foamy virus type 1 transcriptional transactivator (Tas) binds and activates an enhancer element in the gag gene. J Virol 70:6847–6855.
   Google Scholar
• Caprariello AV, Miller RH, Selkirk SM (2009). Foamy virus as a gene transfer vector to the central nervous system. Gene Ther 16:448–452.
   PubMed Web of Science ®Google Scholar
• Delelis O, Lehmann-Che J, Saïb A (2004). Foamy viruses—a world apart. Curr Opin Microbiol 7:400–406.
   Google Scholar
• Enssle J, Jordan I, Mauer B, Rethwilm A (1996). Foamy virus reverse transcriptase is expressed independently from the Gag protein. Proc Natl Acad Sci U S A 93: 4137–4141.
   PubMed Web of Science ®Google Scholar
• Flugel RM, Rethwilm A, Maurer B, Darai G (1987). Nucleotide sequence analysis of the env gene and its flanking regions of the human spumaretrovirus reveal two novel genes. EMBO J 6:2077–2084.
   Google Scholar
• Flugel RM, Spumaviruses (1991). A group of complex retrovirus. J Acquir Immune Defic Syndr 4:739–750.
   PubMed Web of Science ®Google Scholar
• Glorioso JC, Mata M, Fink DJ (2003). Therapeutic gene transfer to the nervous system using viral vectors. J NeuroVirol 9:165–172.
   PubMed Web of Science ®Google Scholar
• Hacein-Bey-Abina S, Kalle CV, Schmidt M, Deist FL, Wulffraat N, McIntyre E, Radford I, Villeval JL, Fraser CC, Cavazzana-Calvo M, Fischer A (2003). A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency. N Engl J Med 348:255–256.
   PubMed Web of Science ®Google Scholar
• Heneine W, Switzer WM, Sandstrom P, Brown J, Vedapuri S, Schable CA, Khan AS, Lerche NW, Schweizer M, Neumann-Haefelin D, Chapman LE, Folks TM (1998). Identification of a human population infected with simian foamy viruses. Nat Med 4:403–407.
   PubMed Web of Science ®Google Scholar
• Josephson NC, Trobridge G, Russell DW (2004). Transduction of long-term and mobilized peripheral blood-derived NOD/SCID repopulating cells by foamy virus vectors. Hum Gene Ther 15:87–92.
   PubMed Web of Science ®Google Scholar
• Khan AS (2009). Simian foamy virus infection in humans:prevalence and management. Expert Rev Anti Infect Ther 7:569–580.
   PubMed Web of Science ®Google Scholar
• Linial M (2000). Why aren't foamy viruses pathogenic? Trends Microbiol 8: 284–289.
   PubMed Web of Science ®Google Scholar
• Lewis PF, Emerman M (1994). Passage through mitosis is required for oncoretroviruses but not for the human immunodeficiency virus. J Virol 68:510–516.
   PubMed Web of Science ®Google Scholar
• Liu W, He X, Cao Z, Sheng J, Liu H, Li Z, Li W (2005). Efficient therapeutic gene expression in cultured rat hippocampal neurons mediated by human foamy virus vectors: a potential for the treatment of neurological diseases. Intervirology 48:329–335.
   Google Scholar
• Liu W, Liu Z, Cao X, Cao Z, Xue L, Zhu F, He X, Li W (2007). Recombinant human foamy virus, a novel vector for neurological disorders gene therapy, drives production of GAD in cultured astrocytes. Mol Ther 15:1834–1841.
   Google Scholar
• Liu W, Liu Z, Liu L, Xiao Z, Cao X, Cao Z, Xue L, Miao L, He X, Li W (2008). A novel human foamy virus mediated gene transfer of GAD67 reduces neuropathic pain following spinal cord injury. Neurosci Lett 432:13–18.
   PubMed Web of Science ®Google Scholar
• Lochelt M, Muranyi W, Flugel RM (1993). Human foamy virus genome possesses an internal Bel-1-dependent and functional promoter. Proc Natl Acad Sci U S A 90:7317–7321.
   PubMed Web of Science ®Google Scholar
• Löchelt M, Yu SF, Linial ML, Flügel RM (1995). The human foamy virus internal promoter is required for efficient gene expression and infectivity. Virology 206:601–610.
   PubMed Web of Science ®Google Scholar
• Lo YT, Tian T, Nadeau PE, Park J, Mergia A (2010). The foamy virus genome remains unintegrated in the nuclei of G1/S phase-arrested cells, and integrase is critical for preintegration complex transport into the nucleus. J Virol 84:2832–2842.
   PubMed Web of Science ®Google Scholar
• Lundberg C, Horellou P, Mallet J, Bjorklund A (1996). Generation of DOPA-producing astrocytes by retroviral transduction of the human tyrosine hydroxylase gene: in vitro characterization and in vivo effects in the rat Parkinson model. Exp Neurol 139:39–53.
   PubMed Web of Science ®Google Scholar
• Marchand F, Jones NG, McMahon SB (2009). Future treatment strategies for neuropathic pain. Handb Exp Pharmacol 194:589–615.
   Google Scholar
• Marshall E (2002). Gene therapy a suspect in leukemia-like disease. Science 298:34–35.
   PubMed Web of Science ®Google Scholar
• Marshall E (2003). Gene therapy. Second child in French trial is found to have leukemia. Science 299:320.
   PubMed Web of Science ®Google Scholar
• Maurer B, Bannert H, Darai G, Flugel RM (1988). Analysis of the primary structure of the long terminal repeat and the gag and pol genes of the human spumaretrovirus. J Virol 62:1590–1597.
   Google Scholar
• Meiering CD, Linial ML (2001). Historical perspective of foamy virus epidemiology and infection. Clin Microbiol Rev 14:165–176.
   PubMed Web of Science ®Google Scholar
• Meredith A, Mintzer, Simanek EE (2009). Nonviral vectors for gene delivery. Chem Res 109:259–302.
   Google Scholar
• Mergia A, Chari S, Kolson DL, Goodenow MM, Ciccarone T (2001). The efficiency of simian foamy virus vector type-1 (SFV-1) in nondividing cells and in human PBLs. Virology 280:243–252.
   Google Scholar
• Miller AD, Miller DG, Garcia JV, Lynch CM (1993). Use of retroviral vectors for gene transfer and expression. Methods Enzymol 217:581–599.
   PubMed Web of Science ®Google Scholar
• Moebes A, Enssle J, Bieniasz PD, Heinkelein M, Lindemann D, Bock M, McClure MO, Rethwilm A (1997). Human foamy virus reverse transcription that occurs late in the viral replication cycle. J Virol 71:7305–7311.
   PubMed Web of Science ®Google Scholar
• Morozov VA, Copeland TD, Nagashima K, Gonda MA, Oroszlan S (1997). Protein composition and morphology of human foamy virus intracellular cores and extracellular particles. Virology 228:307–317.
   Google Scholar
• Patton GS, Morris SA, Chung W, Bieniasz PD, McClure MO (2005). Identification of domains in gag important for prototypic foamy virus egress. J Virol 79:6392–6399.
   PubMedGoogle Scholar
• Picard-Maureau M, Kreppel F, Lindemann D, Juretzek T, Herchenröder O, Rethwilm A, Kochanek S, Heinkelein M (2004). Foamy virus–adenovirus hybrid vectors. Gene Therapy 11:722–728.
   Google Scholar
• Rethwilm A (2007). Foamy virus vectors: an awaited alternative to gammaretro- and lentiviral vectors. Curr Gene 7:261–271.
   Google Scholar
• Ridet JL, Sarkis C, Serguera C, Zennou V, Charneau P, Mallet J (2003). Transplantation of human adult astrocytes: efficiency and safety requirements for an autologous gene therapy. J Neurosci Res 72:704–708.
   Google Scholar
• Roe T, Reynolds TG, Yu G, Brown PO (1993). Intergration of murine leukemia virus DNA depends on mitosis. EMBO J 12:2099–2108.
   PubMed Web of Science ®Google Scholar
• Russell DW, Miller AD (1996). Foamy virus vectors. J Virol 70:217–222.
   PubMed Web of Science ®Google Scholar
• Saïb A, Puvion-Dutilleul F, Schmid M, Périès J, de Thé H (1997). Nuclear targeting of incoming human foamy virus Gag proteins involves a centriolar step. J Virol 71:1155–1161.
   Google Scholar
• Schiephake AW, Rethwilm A (1994). Nuclear localization of foamy virus gag precursor protein. J Virol 68:4946–4954.
   Google Scholar
• Schweizer M, Falcone V, Gange J, Turek R, Neumann-Haefelin D (1997). Simian foamy virus isolated from an accidentally infected human individual. J Virol 71:4821–4824.
   PubMed Web of Science ®Google Scholar
• Schweizer M, Turek R, Hahn H, Schliephake A, Netzer KO, Eder G, Reinhardt M, Rethwilm A, Neumann-Haefelin D (1995). Markers of foamy virus infections in monkeys, apes, and accidentally infected humans: appropriate testing fails to confirm suspected foamy virus prevalence in humans. AIDS Res Hum Retroviruses 11:161–170.
   PubMed Web of Science ®Google Scholar
• Shi N, Pardridge WM (2000). Noninvasive gene targeting to the brain. Proc Natl Acad Sci U S A 97:7567–7572.
   PubMed Web of Science ®Google Scholar
• Snyder EY, Senut MC (1997). The use of nonneuronal cells for gene delivery. Neurobiol Dis 4:69–102.
   PubMed Web of Science ®Google Scholar
• Suzuki Y, Craigie R (2007). The road to chromatin: nuclear entry of retroviruses. Nat Rev Microbiol 5:187–196.
   PubMed Web of Science ®Google Scholar
• Trobridge G, Josephson N, Vassilopoulos G, Mac J, Russell DW (2002). Improved foamy virus vectors with minimal viral sequences. Mol Ther 6:321–328.
   PubMed Web of Science ®Google Scholar
• Trobridge G, Russell DW (2004). Cell cycle requirements for transduction by foamy virus vectors compared to those of oncovirus and lentivirus vectors. J Virol 78:2327–2335.
   PubMed Web of Science ®Google Scholar
• Trobridge GD (2009). Foamy virus vectors for gene transfer. Expert Opin Biol Ther 9:1427–1436.
   PubMed Web of Science ®Google Scholar
• Verma IM, Somia N (1997). Gene therapy. Nature 389:239–242.
   PubMed Web of Science ®Google Scholar
• Vile RG, Rusell SJ (1995). Retroviruses as vectors. Br Med Bull 51:12–30.
   PubMed Web of Science ®Google Scholar
• Weiss RA (1988) Foamy retroviruses. A virus in search of a disease. Nature 333: 497–498.
   PubMed Web of Science ®Google Scholar
• Wolfe ND, Switzer WM, Carr JK, Bhullar VB, Shanmugam V, Tamoufe U, Prosser AT, Torimiro JN, Wright A, Mpoudi-Ngole E, McCutchan FE, Birx DL, Folks TM, Burke DS, Heneine W (2004). Naturally acquired simian retrovirus infections in central African hunters. Lancet 363:932–937.
   PubMed Web of Science ®Google Scholar
• Yu SF, Baldwin DN, Gwynn WR, Yendapalli S, Linial ML (1996a). Human foamy virus replication: a pathway distinct from that of retrovirus and hepadnaviruses. Science 271:1579–1582.
   PubMed Web of Science ®Google Scholar
• Yu SF, Edelman K, Strong RK, Moebes A, Linial ML (1996b). The carboxyl terminus of the human foamy virus Gag protein contains separable nucleic acid binding and nuclear transport domain. J Virol 70:8255–8262.
   PubMed Web of Science ®Google Scholar